LAB Stock Overview
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Laboratory Corporation of America Holdings Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$193.00 |
| 52 Week High | US$218.00 |
| 52 Week Low | US$185.00 |
| Beta | 0.99 |
| 1 Month Change | 0.52% |
| 3 Month Change | -5.39% |
| 1 Year Change | -7.21% |
| 3 Year Change | -11.31% |
| 5 Year Change | 51.92% |
| Change since IPO | 229.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| LAB | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -0.5% | 0.04% | -1.9% |
| 1Y | -7.2% | -5.8% | 1.1% |
Return vs Industry: LAB underperformed the German Healthcare industry which returned -5.8% over the past year.
Return vs Market: LAB underperformed the German Market which returned 1.1% over the past year.
Price Volatility
| LAB volatility | |
|---|---|
| LAB Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 5.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LAB has not had significant price volatility in the past 3 months.
Volatility Over Time: LAB's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 61,975 | Adam Schechter | www.labcorp.com |
Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
Laboratory Corporation of America Holdings Fundamentals Summary
| LAB fundamental statistics | |
|---|---|
| Market cap | €16.29b |
| Earnings (TTM) | €356.87m |
| Revenue (TTM) | €11.45b |
45.1x
P/E Ratio1.4x
P/S RatioIs LAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LAB income statement (TTM) | |
|---|---|
| Revenue | US$12.16b |
| Cost of Revenue | US$8.80b |
| Gross Profit | US$3.36b |
| Other Expenses | US$2.99b |
| Earnings | US$379.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
| Earnings per share (EPS) | 4.51 |
| Gross Margin | 27.67% |
| Net Profit Margin | 3.12% |
| Debt/Equity Ratio | 64.1% |
How did LAB perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield66%
Payout RatioDoes LAB pay a reliable dividends?
See LAB dividend history and benchmarks| Laboratory Corporation of America Holdings dividend dates | |
|---|---|
| Ex Dividend Date | May 24 2024 |
| Dividend Pay Date | Jun 12 2024 |
| Days until Ex dividend | 38 days |
| Days until Dividend pay date | 57 days |
Does LAB pay a reliable dividends?
See LAB dividend history and benchmarks